Reparixin in Pancreatic Islet Transplantation

NCT01220856 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Islet Transplantation in Type 1 Diabetes Mellitus

Interventions

DRUG: Reparixin

Sponsor

Dompé Farmaceutici S.p.A